Igene Biotechnology IncOver The Counter Market:IGNE
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Igene Biotechnology Inc | 1.6K | 0.0x | --- |
Itronics Inc | 20.0 | 0.0x | --- |
Humatech Inc | 9.5K | -0.1x | --- |
Greensmart Corp | 40.0 | 0.0x | --- |
Arcadia Biosciences Inc | 3.7M | -1.3x | --- |
Senestech Inc | 1.2M | -0.1x | --- |
Company Information
IGENE Biotechnology, Inc. (Igene) is focused on the research, development, production and commercialization of specialty ingredients for human and animal nutrition. The Company develops, produces and markets specialty biochemical products. It is a supplier of natural astaxanthin, a nutrient in different feed applications and a source of pigment for coloring farmed salmon species. Igene provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors. It also provides analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. Within animal nutrition, the Company focus is to deliver astaxanthin to the fish feed market.
Contact Information
- Headquarters
- 9110 Red Branch Rd, Suite JCOLUMBIA, MD, United States 21045-2024
- Phone
- 410-997-2599
- Fax
- 410-730-0540
Executives
- Chairman of the Board
- Michael Kimelman
- President, Chief Technical Officer, Treasurer, Director of R&D, Director
- Stephen Hiu
- Vice Chairman of the Board
- Thomas Kempner
- Chief Financial Officer
- Edward Weisberger
- Vice President, Secretary, Director of Manufacturing, Director
- Patrick Monahan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6K |
|---|---|
Revenue (TTM) | $3.9K |
Shares Outstanding | 1.6B |
Igene Biotechnology Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59,804.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
